IPOs Positive

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

Breaking news from global financial markets

il y a 2 semaines
Lire Plus